Study Maps 127 DNA Regions Tied to Alzheimer's Risk
An international genetic analysis of about 2.8 million people points to new genes and neuron types linked to the disease.
Updated on Nov. 10, 2026 in Alzheimer’s
Live Poll
Do you trust scientists to find effective treatments for Alzheimer's disease?
A genetic study led by Vrije Universiteit Amsterdam identified 127 regions of human DNA associated with Alzheimer's risk, 48 of which had not previously been mapped in this context. The findings, published in Nature, pooled data from 30 research groups under the International Psychiatric Genomics Consortium.
Why it matters
Genes play a substantial role in Alzheimer's risk, yet scientists do not fully understand which genes matter or how they influence the disease. The results offer new starting points for research into potential future treatments.
The analysis drew on about 2.8 million people, including 183,620 with Alzheimer's, and identified 127 DNA regions linked to risk. Whether these associations are causal has not yet been established and requires follow-up research.
The players
Vrije Universiteit Amsterdam
A Dutch public research university in Amsterdam that led the international team behind the genetic analysis.
University of Oslo
Norway's largest and oldest university, which co-led the study with the Amsterdam team.
International Psychiatric Genomics Consortium
A large collaborative network of researchers that coordinates genetic studies of psychiatric and neurological conditions across institutions worldwide.
The details
Researchers analyzed genetic data from people with diverse backgrounds and found that several specific types of neurons were enriched for genetic signals tied to the disease. The study also strengthened evidence for the involvement of microglia, immune cells of the brain, in Alzheimer's.
Timeline
28 October 2026: Study published in Nature.
By 2050: Dementia is projected to affect more than 150 million people worldwide.
Health Landscape
The study extends the International Psychiatric Genomics Consortium's model of pooling data across research groups to Alzheimer's, a method that can detect associations smaller studies miss. It adds to a growing body of genetic research aimed at identifying biological targets for a disease projected to affect more than 150 million people by 2050.
The findings do not yet translate into new treatments or changed daily health routines for patients. They do, however, point to specific genes and cell types that future drug research may target.
The takeaway
Genetic research at this scale is beginning to map biological pathways behind Alzheimer's, which may guide the search for future therapies. Readers should treat the findings as early leads rather than established causes.
Further reading
Explore more on Alzheimer's research and risk factors.
More information
Read the full Nature study on Alzheimer's disease genetics.
Live Poll
Do you trust scientists to find effective treatments for Alzheimer's disease?
